Clinical Trials

50 enrolled

Digestive System Neoplasms

NCT06828328 2025-12-23

A Study of GC203 TIL in PDCA (RJ)

10 enrolled

Pancreatic Neoplasms

NCT05098197 2025-12-11

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

50 enrolled

Advanced Liver Cancers

NCT07166263 2025-09-10

Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

15 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT06675513 2025-05-20

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

30 enrolled

Phase EARLY_PHASE1 Completed

Colorectal Neoplasms

NCT06797427 2025-03-17

A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers

12 enrolled

Carcinoma, Hepatocellular

NCT06646783 2024-10-17

Phase IIT Trial of SNA014

28 enrolled

Adenocarcinoma of the Stomach

NCT06645301 2024-10-16

BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies

15 enrolled

Pancreatic Neoplasms, Colorectal Neoplasms

NCT06645314 2024-10-16

Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma

16 enrolled

Phase EARLY_PHASE1 Withdrawn

Carcinoma, Hepatocellular

NCT06284226 2024-04-16

CCT-ANK-11

GastrointestinalGynecologicThoracic

Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05465590 2023-12-21

A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06173726 2023-12-18

Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer

6 enrolled

Liver Neoplasms

NCT06152757 2023-12-01

BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors

14 enrolled

Digestive System Neoplasms

NCT06098898 2023-10-25

Safety and Efficacy of NK510 to Treat Gastric Cancer

9 enrolled

Stomach Neoplasms

NCT05648955 2023-07-28

ALLIES

118 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

20 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT05886075 2023-06-02

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

24 enrolled

Breast Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

BreastGastrointestinalSarcomaThoracic

20 enrolled

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT05830240 2023-04-26

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer